Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience
- PMID: 20198518
- PMCID: PMC3213118
- DOI: 10.1007/s12015-010-9125-6
Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience
Abstract
Genostem (acronym for "Adult mesenchymal stem cells engineering for connective tissue disorders. From the bench to the bed side") has been an European consortium of 30 teams working together on human bone marrow Mesenchymal Stem Cell (MSC) biological properties and repair capacity. Part of Genostem activity has been dedicated to the study of basic issues on undifferentiated MSCs properties and on signalling pathways leading to the differentiation into 3 of the connective tissue lineages, osteoblastic, chondrocytic and tenocytic. We have evidenced that native bone marrow MSCs and stromal cells, forming the niche of hematopoietic stem cells, were the same cellular entity located abluminally from marrow sinus endothelial cells. We have also shown that culture-amplified, clonogenic and highly-proliferative MSCs were bona fide stem cells, sharing with other stem cell types the major attributes of self-renewal and of multipotential priming to the lineages to which they can differentiate (osteoblasts, chondrocytes, adipocytes and vascular smooth muscle cells/pericytes). Extensive transcription profiling and in vitro and in vivo assays were applied to identify genes involved in differentiation. Thus we have described novel factors implicated in osteogenesis (FHL2, ITGA5, Fgf18), chondrogenesis (FOXO1A) and tenogenesis (Smad8). Another part of Genostem activity has been devoted to studies of the repair capacity of MSCs in animal models, a prerequisite for future clinical trials. We have developed novel scaffolds (chitosan, pharmacologically active microcarriers) useful for the repair of both bone and cartilage. Finally and most importantly, we have shown that locally implanted MSCs effectively repair bone, cartilage and tendon.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Figures



Similar articles
-
Bone marrow mesenchymal stem cells: historical overview and concepts.Hum Gene Ther. 2010 Sep;21(9):1045-56. doi: 10.1089/hum.2010.115. Hum Gene Ther. 2010. PMID: 20565251 Free PMC article. Review.
-
Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9. Stem Cell Res Ther. 2017. PMID: 28446235 Free PMC article.
-
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.Vox Sang. 2008 Aug;95(2):137-48. doi: 10.1111/j.1423-0410.2008.01076.x. Epub 2008 Jun 28. Vox Sang. 2008. PMID: 18557828
-
Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.Stem Cell Rev Rep. 2017 Oct;13(5):611-630. doi: 10.1007/s12015-017-9748-y. Stem Cell Rev Rep. 2017. PMID: 28597211
-
Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation.Exp Cell Res. 2005 Jun 10;306(2):330-5. doi: 10.1016/j.yexcr.2005.03.018. Epub 2005 Apr 15. Exp Cell Res. 2005. PMID: 15925588 Review.
Cited by
-
The miR151 and miR5100 Transfected Bone Marrow Stromal Cells Increase Myoblast Fusion in IGFBP2 Dependent Manner.Stem Cell Rev Rep. 2022 Aug;18(6):2164-2178. doi: 10.1007/s12015-022-10350-y. Epub 2022 Feb 21. Stem Cell Rev Rep. 2022. PMID: 35190967 Free PMC article.
-
Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential.Stem Cell Rev Rep. 2013 Feb;9(1):32-43. doi: 10.1007/s12015-012-9365-8. Stem Cell Rev Rep. 2013. PMID: 22529014 Free PMC article.
-
A Review on the Effect of Plant Extract on Mesenchymal Stem Cell Proliferation and Differentiation.Stem Cells Int. 2019 Jul 24;2019:7513404. doi: 10.1155/2019/7513404. eCollection 2019. Stem Cells Int. 2019. PMID: 31428160 Free PMC article. Review.
-
Bone marrow mesenchymal stem cells: historical overview and concepts.Hum Gene Ther. 2010 Sep;21(9):1045-56. doi: 10.1089/hum.2010.115. Hum Gene Ther. 2010. PMID: 20565251 Free PMC article. Review.
-
Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function.Front Immunol. 2021 Mar 8;12:606781. doi: 10.3389/fimmu.2021.606781. eCollection 2021. Front Immunol. 2021. PMID: 33763061 Free PMC article. Review.
References
-
- Delorme B, Charbord P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med. 2007;140:67–81. - PubMed
-
- Dimitriou H, Linardakis E, Martimianaki G, et al. Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases. Cytotherapy. 2008;10(2):125–33. - PubMed
-
- Delorme B, Ringe J, Pontikoglou C, et al. Specific Lineage-Priming of Bone Marrow Mesenchymal Stem Cells Provides the Molecular Framework for Their Plasticity. Stem Cells. 2009;27(5):1142–51. - PubMed
-
- Peiffer I, Eid P, Barbet R, et al. A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon alpha/beta. Leukemia. 2007;21(4):714–24. - PubMed
-
- Delorme B, Ringe J, Gallay N, et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood. 2008;111(5):2631–5. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous